African health experts commit to accelerate efforts to eliminate Neglected Tropical Diseases

0 0
Read Time:3 Minute, 25 Second

WHO is working closely with Member States and partners to adapt public health strategies, enhance surveillance, and ensure timely responses to evolving NTDs challenges

African health experts have renewed commitment to accelerate efforts to end Neglected Tropical Diseases (NTDs) that continue to affect over a billion people globally, 40% of whom live in the African region.

Meeting in Togo from 15 to 17 April 2025 for the NTD Programme Managers meeting, the experts also set in motion discussions and collaborations aimed at driving bold and more strategic approaches to end NTDs in Africa.

The African region is home to twenty of the 21 recognized NTDs, including river blindness, lymphatic filariasis, leprosy, and several skin diseases that disproportionately affect the poorest and most marginalized communities. These diseases can cause severe disabilities, social stigma, and even death. Despite progress in recent years, all 47 countries in the WHO African Region remain endemic for at least one NTD, and 37 are battling five or more concurrently.

“We must step up our efforts while ensuring that no one is left behind,” said Dr Chikwe Ihekweazu, Acting WHO Regional Director for Africa. “As we reach the mid-point of the 2021–2030 NTD Roadmap, it’s not just a moment of reflection—it’s a call to action.”
The three-day hybrid meeting brought together over 45 national programme managers and various stakeholders, including global health partners and civil society organizations. The health leaders committed to enhance country leadership and increase domestic financing for NTD programmes to ensure long-term sustainability, accelerate the adoption of innovative diagnostic tools, digital technologies, and treatment methods to improve disease prevention, detection and patient care, strengthen national and community-based surveillance systems to track disease outbreaks and monitor progress more effectively and develop concrete national action plans to address persistent gaps in access to prevention and treatment services, particularly in underserved populations.

The meeting, organized with support from the Kuwait Fund and other partners, was an opportunity for participants to reflect on key milestones, identify challenges, and shape effective strategies for NTD elimination. Representing the Minister of Health and Public Hygiene of Togo, Dr Wotobe Kokou commended the country’s leadership in eliminating four NTDs—Guinea Worm, Lymphatic Filariasis, Human African Trypanosomiasis, and Trachoma—making Togo the first in the region to achieve this milestone.

“These successes are the result of strong political commitment, close collaboration with our partners, and exemplary community engagement. They demonstrate that with concerted efforts and innovative strategies, eliminating neglected tropical diseases is possible,” he said.

Dr Amadou Bailo Diallo, WHO Representative in Togo, also lauded Togo’s achievements and reaffirmed the importance of multisectoral and community-centered approaches in fighting NTDs.

“With funding cuts and climate change posing emerging threats to global health programmes, including NTD elimination efforts, addressing NTDs requires not just innovative strategies, but targeted support that focuses on the most vulnerable communities.” Dr Dorothy Achu, Team Lead for Tropical Vector-Borne Diseases at WHO Regional Office for Africa. “We must ensure diseases disproportionately affecting the poorest and most marginalized populations receive needed attention and resources, particularly those that can be eliminated. With sustained efforts, we can end the burden of NTDs on Africa’s communities”.

WHO is working closely with Member States and partners to adapt public health strategies, enhance surveillance, and ensure timely responses to evolving NTDs challenges.  By convening NTD stakeholders, disseminating guidelines, strengthening governance, and providing technical support in strategic and operational planning, policy development, capacity building, and strengthening surveillance, monitoring, and evaluation systems, the Programme Managers’ meeting is a WHO initiative aimed at supporting country leadership and governance, with ongoing support from the Regional Programme Advisory Group

The 2025 NTD Programme Managers’ Meeting reinforces the commitment of the WHO AFRO and its partners to eliminate NTDs and improve the health and well-being of communities across the African Region. The meeting significantly contributes to aligning national and regional efforts with the global roadmap for NTD elimination and achieving Sustainable Development Goals (SDGs). With renewed momentum, African countries are signalling a united front to bring an end to these preventable and treatable diseases.

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

About Author

You may have missed

Lusaka — African health ministers and partners are calling for increased investment in integrated health services to address the growing burden of severe noncommunicable diseases (NCDs), particularly those affecting women and underserved populations across the region. At a high-level side event during the Seventy-fifth session of the WHO Regional Committee for Africa, delegates emphasized the urgent need for equitable access to prevention, screening, treatment, and rehabilitation across the continuum of care for NCDs. Disparities are especially pronounced in rural areas, where health infrastructure and services remain inadequate. Breast and cervical cancers are among the leading causes of cancer-related deaths among women in sub-Saharan Africa—particularly cervical cancer, which is both preventable and treatable. It remains the most common cause of cancer death for women in the region. In 2022, Africa accounted for nearly a quarter (23%) of the 76 000 global cervical cancer deaths. Meanwhile, severe NCDs such as Type 1 diabetes, sickle cell disease, and heart conditions claim more than half a million lives annually, including among children, adolescents, and young adults in some of the continent’s poorest communities. Inequitable access to health services continues to hinder efforts to reduce this burden. To improve cervical and breast cancer care in the region, urgent investment is needed in leadership, governance, and financing. Strengthening these foundations is critical in the current funding landscape. Advancements in strategic planning, healthcare infrastructure, workforce training, and—most importantly—equitable access to screening, diagnostic, and treatment services are essential. To address these challenges, WHO and its partners showcased successful integrated models such as the Women’s Integrated Care for Cancer Services (WICS), the BEAT Breast Cancer Project, and the PEN-Plus Strategy. WICS strengthens early detection, treatment, and integration of women’s cancer services into primary health care systems in Côte d’Ivoire, Kenya, and Zimbabwe. The BEAT Breast Cancer Project is a transformative multi-year initiative aimed at reducing breast cancer mortality among women in Tanzania and Ghana through early detection, timely diagnosis, and comprehensive treatment access. “PEN-Plus, WICS and the BEAT Breast Cancer Initiative are models for a new standard of care, rooted in equity, access and health justice. I urge countries to prioritize policies that embed these models into broader health system strengthening, said Dr Mohamed Janabi, WHO Regional Director for Africa”. Côte d’Ivoire offers a compelling example of progress, combining high HPV vaccination coverage—reaching over three million girls (91.4%)—with WICS-supported community-based screening campaigns to strengthen cervical cancer prevention. In Kenya, cervical cancer screening has been successfully integrated into national health services. “This gathering marks a pivotal moment to accelerate action for breast cancer prevention in Africa. We deeply value the leadership of the Ministries of Health of Ghana and Tanzania, and the steadfast support of the Pfizer Foundation in helping us achieve this milestone. The side event builds momentum for the policy prioritization of women’s cancers, partnerships to strengthen the broader women’s cancer ecosystem, and advance a health-systems approach to breast cancer prevention and management”, said Dr Somesh Kumar, Senior Director, Jhpiego. PEN-Plus expands access to care for severe NCDs at the district hospital level. Since its implementation, 20 countries in Africa have increased access to services for severe NCDs. Over 15 000 people are currently receiving treatment for chronic conditions such as sickle cell disease and Type 1 diabetes through PEN-Plus clinics.